Видання зареєстровані авторами шляхом самоархівування

Permanent URI for this communityhttps://devessuir.sumdu.edu.ua/handle/123456789/1

Browse

Search Results

Now showing 1 - 2 of 2
  • Item
    Elective surgeries during and after the COVID-19 pandemic: Case burden and physician shortage concerns
    (Wolters Kluwer, 2022) Mehta, A.; Awuah, W.A.; Ng, J.C.; Kundu, M.; Yarlagadda, R.; Sen, M.; Nansubuga, E.P.; Abdul-Rahman, T.; Hasan, M.M.
    The COVID-19 pandemic had a significant impact on several aspects of global healthcare systems, particularly surgical services. New guidelines, resource scarcity, and an ever-increasing demand for care have posed challenges to healthcare professionals, resulting in the cancellation of many surgeries, with short and long-term consequences for surgical care and patient outcomes. As the pandemic subsides and the healthcare system attempts to reestablish a sense of normalcy, surgical recommendations and advisories will shift. These changes, combined with a growing case backlog (postponed surgeries + regularly scheduled surgeries) and a physician shortage, can have serious consequences for physician health and, as a result, surgical care. Several initiatives are already being implemented by governments to ensure a smooth transition as surgeries resume. Newer and more efficient steps aimed at providing adequate surgical care while preventing physician burnout, on the other hand, necessitate a collaborative effort from governments, national medical boards, institutions, and healthcare professionals. This perspective aims to highlight alterations in surgical recommendations over the course of the pandemic and how these changes continue to influence surgical care and patient outcomes as the pandemic begins to soften its grip.
  • Item
    Concern over Nipah virus cases amidst the COVID-19 pandemic in India
    (Willey, 2022) Aborode, A.T.; Wireko, A.A.; Mehta, A.; Abdul-Rahman, T.; Nansubuga, E.P.; Kundu, M.; Pustake, M.; Mehmood, Q.; Tillewein, H.
    Nipah virus, a member of the paramyxoviridae family, is classified as a“virus of concern” by the World Health Organization (WHO).1,2 Nipahvirus is usually reported in Southeast Asia due to the geographicalprevalence of its natural host, thePteropusfruit bat.1,3It is a zoonoticinfection transmitted by direct contact with infected animals or viabodily secretions such as bat blood, saliva, and urine. The virus alsodemonstrates human–human transmission.4Nipah virus infectiongenerally affects the central nervous system in human hosts, causinginflammation of brain parenchyma (encephalitis) and can also causerespiratory symptoms.3Initial symptoms include fever, headache, later progressing to drowsiness, altered mental status, coma, andeven death.5As reported by Kenmoe et al. Nipah virus encephalitishas a pooled case fatality rate of 61%.6The current managementincludes symptomatic treatment due to lack of specific pharmaco-logical treatment for Nipah virus.